Market closed
Align Technology/$ALGN
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Align Technology
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Ticker
$ALGN
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
21,690
Website
Align Technology Metrics
BasicAdvanced
$16B
37.73
$5.62
1.67
-
Price and volume
Market cap
$16B
Beta
1.67
52-week high
$335.40
52-week low
$196.09
Average daily volume
758K
Financial strength
Current ratio
1.223
Quick ratio
1.001
Long term debt to equity
2.29
Total debt to equity
2.29
Management effectiveness
Return on assets (TTM)
6.87%
Return on equity (TTM)
11.26%
Valuation
Price to earnings (TTM)
37.728
Price to revenue (TTM)
3.97
Price to book
4.1
Price to tangible book (TTM)
4.77
Price to free cash flow (TTM)
21.506
Growth
Revenue change (TTM)
3.54%
Earnings per share change (TTM)
-3.27%
3-year revenue growth (CAGR)
0.39%
3-year earnings per share growth (CAGR)
-16.61%
What the Analysts think about Align Technology
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Align Technology stock.
Align Technology Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Align Technology Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Align Technology News
AllArticlesVideos
Invisalign® Palatal Expander System by Align Technology Now Available in Turkey for Skeletal and Dental Expansion in Growing Patients
Business Wire·2 days ago
Align Technology, Inc. (ALGN) Q4 2024 Earnings Call Transcript
Seeking Alpha·6 days ago
Align forecasts downbeat Q1 revenue on soft demand for teeth aligners
Reuters·6 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Align Technology stock?
Align Technology (ALGN) has a market cap of $16B as of February 12, 2025.
What is the P/E ratio for Align Technology stock?
The price to earnings (P/E) ratio for Align Technology (ALGN) stock is 37.73 as of February 12, 2025.
Does Align Technology stock pay dividends?
No, Align Technology (ALGN) stock does not pay dividends to its shareholders as of February 12, 2025.
When is the next Align Technology dividend payment date?
Align Technology (ALGN) stock does not pay dividends to its shareholders.
What is the beta indicator for Align Technology?
Align Technology (ALGN) has a beta rating of 1.67. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.